Nova Leap Health Corp. (TSXV: NLH)
Canada
· Delayed Price · Currency is CAD 0.255
0.00 (0.00%)
Nov 21, 2024, 9:30 AM EST
Nova Leap Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 25.73 | 26.18 | 28.21 | 21.28 | 17.31 | 17.4 | Upgrade
|
| Revenue Growth (YoY) | -2.58% | -7.18% | 32.55% | 22.93% | -0.55% | 67.96% | Upgrade
|
| Cost of Revenue | 15.81 | 16.41 | 18.23 | 14.07 | 11.44 | 11.56 | Upgrade
|
| Gross Profit | 9.92 | 9.77 | 9.98 | 7.21 | 5.87 | 5.84 | Upgrade
|
| Selling, General & Admin | 8.34 | 8.42 | 9.68 | 7.58 | 5.72 | 5.34 | Upgrade
|
| Operating Expenses | 8.96 | 9.31 | 11.04 | 8.44 | 6.27 | 5.96 | Upgrade
|
| Operating Income | 0.96 | 0.46 | -1.06 | -1.23 | -0.4 | -0.11 | Upgrade
|
| Interest Expense | -0.07 | -0.14 | -0.41 | -0.36 | -0.52 | -0.46 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.05 | -0.4 | 0.93 | -0.07 | -0.2 | -0.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.02 | -0.04 | -0.03 | -0.05 | - | Upgrade
|
| EBT Excluding Unusual Items | 0.81 | -0.11 | -0.58 | -1.69 | -1.16 | -0.83 | Upgrade
|
| Merger & Restructuring Charges | -0.17 | -0.11 | -0.26 | -0.34 | -0.2 | -0.12 | Upgrade
|
| Impairment of Goodwill | -1.15 | -1.5 | -0.51 | -0.61 | -0.8 | - | Upgrade
|
| Legal Settlements | - | 0.35 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.03 | - | 0.14 | 5.11 | 2.29 | - | Upgrade
|
| Pretax Income | -0.48 | -1.37 | -1.21 | 2.47 | 0.13 | -0.95 | Upgrade
|
| Income Tax Expense | -0.02 | -0.31 | -0.37 | 0.71 | -1.13 | 0.1 | Upgrade
|
| Net Income | -0.46 | -1.05 | -0.84 | 1.76 | 1.26 | -1.06 | Upgrade
|
| Net Income to Common | -0.46 | -1.05 | -0.84 | 1.76 | 1.26 | -1.06 | Upgrade
|
| Net Income Growth | - | - | - | 40.15% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 86 | 86 | 81 | 74 | 65 | 61 | Upgrade
|
| Shares Outstanding (Diluted) | 86 | 86 | 81 | 78 | 66 | 61 | Upgrade
|
| Shares Change (YoY) | -0.02% | 5.83% | 4.90% | 16.89% | 9.17% | 25.60% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | 0.02 | 0.02 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | 0.02 | 0.02 | -0.02 | Upgrade
|
| EPS Growth | - | - | - | 3.66% | - | - | Upgrade
|
| Free Cash Flow | 1.6 | 2.13 | 0.95 | 2.18 | 3.01 | 0.57 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 | 0.01 | Upgrade
|
| Gross Margin | 38.56% | 37.31% | 35.37% | 33.89% | 33.92% | 33.58% | Upgrade
|
| Operating Margin | 3.73% | 1.76% | -3.77% | -5.79% | -2.29% | -0.65% | Upgrade
|
| Profit Margin | -1.80% | -4.03% | -2.96% | 8.27% | 7.26% | -6.07% | Upgrade
|
| Free Cash Flow Margin | 6.24% | 8.12% | 3.37% | 10.24% | 17.36% | 3.28% | Upgrade
|
| EBITDA | 1.23 | 0.99 | -0.07 | -0.56 | 0.02 | 0.39 | Upgrade
|
| EBITDA Margin | 4.80% | 3.80% | -0.24% | -2.65% | 0.09% | 2.26% | Upgrade
|
| D&A For EBITDA | 0.27 | 0.53 | 0.99 | 0.67 | 0.41 | 0.51 | Upgrade
|
| EBIT | 0.96 | 0.46 | -1.06 | -1.23 | -0.4 | -0.11 | Upgrade
|
| EBIT Margin | 3.73% | 1.76% | -3.77% | -5.79% | -2.29% | -0.65% | Upgrade
|
| Effective Tax Rate | - | - | - | 28.81% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.